Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-02-21 @ 9:10 AM
Study NCT ID:
NCT01412333
Status:
COMPLETED
Last Update Posted:
2024-03-08
First Post:
2011-08-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Multiple Sclerosis | View |
Keywords: